Abstract
AbstractTwenty‐two consecutive previously untreated children with stage III and IV non‐lymphoblastic non‐Hodgkin's lymphoma (NHL) and with B‐acute lymphoblastic leukemia (B‐ALL) were treated according to the Murphy‐Bowman protocol. The remission rate was 82%. The estimated long‐term survival rate was 49% and the event‐free survival 41% (in stage III 57% and 53% and in stage IV and B‐ALL 20% and 0%, respectively). The protocol is effective in stage III but fails in stage IV and B‐ALL, which corresponds to the results obtained by other investigators using this or similar protocols.(Acta Paediatr Jpn 1988; 30: 204–208)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
